Skip to main content

New Lead for the National Institute of Allergy and Infectious Diseases

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

WEDNESDAY, Aug. 2, 2023 -- Jeanne Marrazzo, M.D., was named on Wednesday to become the next head of the U.S. National Institute of Allergy and Infectious Diseases, a job most recently held by Anthony Fauci, M.D., well known for his work on HIV and the pandemic.

Marrazzo will start her new job in the fall. She is currently the director of the Division of Infectious Diseases at the University of Alabama at Birmingham.

"Dr. Marrazzo brings a wealth of leadership experience from leading international clinical trials and translational research, managing a complex organizational budget that includes research funding and mentoring trainees in all stages of professional development," Lawrence Tabak, M.D., acting director for the U.S. National Institutes of Health (NIH), said in an NIH news release. "I look forward to welcoming Dr. Marrazzo to the NIH leadership team."

Marrazzo's background includes research on the human microbiome and its role in female reproductive tract infections and hormonal contraception, preventing HIV using biomedical interventions and management of bacterial vaginosis, sexually transmitted diseases in HIV-infected persons, and management of antibiotic resistance in gonorrhea.

She has been a principal investigator on NIH grants since 1997. Marrazzo has also mentored countless trainees, including on NIH-funded training grants. Marrazzo received the American Sexually Transmitted Diseases Association Distinguished Career Award, which is the highest recognition of contributions to research and mentoring in the field. Her education includes a bachelor's degree in biology from Harvard University; a Master's of Public Health in Epidemiology from the University of Washington in Seattle; and an M.D. from Thomas Jefferson University in Philadelphia.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

Peanut Consumption Starting in Infancy Provides Lasting Tolerance

THURSDAY, May 30, 2024 -- Peanut consumption starting in infancy and continuing to age 5 years provides lasting tolerance into adolescence, according to a study published in the...

Inappropriate Antibiotic Prescribing Identified in Safety-Net Populations

THURSDAY, May 30, 2024 -- Inappropriate antibiotic prescribing is common with or without a plausible antibiotic indication, and inappropriate prescribing is also common in U.S...

Following Drop After COVID-19 Onset, Inappropriate Antibiotic Prescribing Is Up

WEDNESDAY, May 1, 2024 -- There was an initial decrease in inappropriate antibiotic prescriptions following onset of COVID-19, followed by an increase, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.